Top Markets
Coin of the day
TaiwanJ Pharmaceuticals Co., Ltd. TaiwanJ Pharmaceuticals Co., Ltd.

TaiwanJ Pharmaceuticals Co., Ltd.

6549
Classement en actions #30195
TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm... TaiwanJ Pharmaceuticals Co., Ltd. operates as a specialized biotech firm dedicated to the research, development, and commercialization of small molecule therapeutics. Initially, its focus within Taiwan has been on tackling chronic organ inflammation stemming from metabolic, autoimmune, or infectious causes. The company's growing pipeline also features specific compounds like JKB-122 and JKB-121, alongside a collection of innovative chemical entities. These new drugs are being developed to address persistent liver conditions and allergic respiratory ailments, such as asthma. TaiwanJ's comprehensive product portfolio is engineered to combat a wide array of diseases, encompassing hepatic inflammation and fibrosis, non-alcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), various autoimmune disorders, asthma, and atopic dermatitis (eczema). Established in 2011, the company's operations are headquartered in Zhubei, Taiwan.
Prix de l'action
$0.22227521
Capitalisation boursière
$17.81M
Changement (1 jour)
0.00%
Changement (1 an)
-14.81%
Pays
TW
Échange TaiwanJ Pharmaceuticals Co., Ltd. (6549)

Catégorie

Historique du rendement du dividende pour TaiwanJ Pharmaceuticals Co., Ltd. (6549)
Le rendement du dividende (TTM) de TaiwanJ Pharmaceuticals Co., Ltd. (symbole boursier : 6549) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de TaiwanJ Pharmaceuticals Co., Ltd. (6549) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes
Entreprise Rendement du dividende Pays
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE